First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial Marinkovich, M. P., Sridhar, K., Gurevich, I., Ponakala, A., Boddu, S., Keene, D., Vinzant, S., Agarwal, P., Krishnan, S. ELSEVIER SCIENCE INC. 2019: S66

View details for Web of Science ID 000465561503101